ZTS — Zoetis Inc.

—
NYSE · Health Care · Pharmaceuticals · CIK 1555280 ·
Last close
$71.43
Market Cap
$29.52B
52W High
$145.99
52W Low
$69.52
ADV30
4,618,082
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 2,468,000,000 1,795,000,000 999,000,000 691,000,000 15,077,000,000 1,473,000,000 11,929,000,000
Mar 2026 2,262,000,000 1,621,000,000 822,000,000 601,000,000 15,154,000,000 1,940,000,000 11,921,000,000
Dec 2025 2,387,000,000 1,675,000,000 826,000,000 603,000,000 15,467,000,000 2,310,000,000 12,136,000,000
Sep 2025 2,400,000,000 1,717,000,000 936,000,000 721,000,000 15,159,000,000 2,080,000,000 9,761,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,840,000,000
Investing CF
$-720,000,000
Financing CF
$-2,282,000,000
CapEx
$-524,000,000
Dividends Paid
$-889,000,000
Buybacks
$-3,644,000,000
EPS Diluted TTM
$6.07
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$14,653,000,000
Inventory
$2,574,000,000
Receivables
$1,571,000,000
ST Investments
$200,000,000
EBIT TTM
$3,510,000,000
Pretax Income TTM
$3,272,000,000
Interest Exp TTM
$238,000,000
Analysts
16

Yahoo Snapshot (yfinance, live)

Total Revenue
$9,525,000,192
EBITDA
$4,065,999,872
Free Cash Flow
$2,016,999,936
Enterprise Value
$37,731,926,016
Total Cash
$1,676,000,000
Total Debt
$9,255,000,064
Shares Out
413,223,602
Trailing EPS
$6.13
Book Value
$7.84
ROE
64.9%
ROA
15.4%
Div Yield
2.91%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 9,467,000,000 3,597,000,000 2,673,000,000 15,467,000,000 12,136,000,000 3,331,000,000 2,904,000,000
Dec 2024 9,256,000,000 3,392,000,000 2,486,000,000 14,237,000,000 9,467,000,000 4,770,000,000 2,953,000,000
Dec 2023 8,544,000,000 3,069,000,000 2,344,000,000 14,286,000,000 9,295,000,000 4,997,000,000 2,353,000,000
Dec 2022 8,080,000,000 2,928,000,000 2,114,000,000 14,925,000,000 10,522,000,000 4,405,000,000 1,912,000,000

TTM Snapshot

Revenues TTM
$8,739,000,000
NetIncome TTM
$2,409,000,000
OpCashFlow TTM
$0
Assets (Latest)
$15,490,000,000
Forward EPS
$6.53

Max Pain — expiry 2026-10-16

max pain strike: $75.00 · spot: $71.43 · call oi: 16,286 · put oi: 12,527
Expected Move to 2026-10-16: ±$3.92 (5.49%) — implied range $67.51 – $75.36 · ATM straddle on $70.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
BEIGF BeOne Medicines Ltd. $29.75B $21.95 —
ROIV Roivant Sciences Ltd. $26.71B $36.98 —
RPRX Royalty Pharma plc $25.99B $58.37 —
INSM INSMED Inc $25.70B $117.67 —
ALNY ALNYLAM PHARMACEUTICALS, INC. $34.17B $255.36 —

News headlines (Yahoo Finance, 1h cache)

Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
2026-09-24 21:15 · Yahoo
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
2026-09-24 11:30 · Yahoo
Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis
2026-09-24 10:19 · Yahoo
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note
2026-09-18 22:15 · Yahoo
Zoetis (ZTS) Stock Fair Value Falls After Mixed Analyst Cuts And Softer Growth Views
2026-09-18 08:13 · Yahoo
Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales
2026-09-18 05:02 · Yahoo
Zoetis (ZTS) Shares Drop After Earnings Revision
2026-09-08 14:51 · Yahoo
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030
2026-09-07 10:38 · Yahoo
Is Zoetis Stock Underperforming the S&P 500?
2026-09-03 11:56 · Yahoo
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
2026-09-02 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.